What is RubiconMD?
RubiconMD provides innovative primary care solutions, focusing on enhancing efficiency and accessibility within the healthcare system. The company offers sophisticated eConsult and Behavioral Health platforms designed to support healthcare providers. Established in 2013 and headquartered in New York, New York, RubiconMD aims to bridge gaps in care delivery through technology, facilitating better patient outcomes and more streamlined clinical workflows. Its strategic focus on integrating technology into primary care positions it as a key player in the evolving healthcare landscape.
How much funding has RubiconMD raised?
RubiconMD has raised a total of $161.3M across 4 funding rounds:
Unspecified
$1.3M
Series A
$4M
Series B
$138M
Series C
$18M
Unspecified (2014): $1.3M with participation from Oxeon Investments, Waterline Ventures, and Athenahealth
Series A (2016): $4M led by Waterline Ventures and Alma Mundi Fund
Series B (2018): $138M supported by Optum Ventures, Centene Corporation, Blue Ivy Ventures, HLM Venture Partners, and Mundi Ventures
Series C (2020): $18M featuring Optum Ventures, Heritage Provider Network Inc, Waterline Ventures, HLM Venture Partners, and Deerfield Communications Inc
Key Investors in RubiconMD
Optum Ventures
Optum Ventures was created to make health care better for everyone. They invest in early-stage companies that are poised to disrupt the status quo.
Waterline Ventures
Waterline Ventures is an investment firm focused on early growth technology and service-enabled technology companies within the healthcare sector, aiming to build lifetime relationships with entrepreneurs.
Mundi Ventures
Mundi Ventures is an investment firm that supports bold and purpose-driven founders in various sectors including deep tech, insurtech, fintech, and climate tech, focusing on backing innovative entrepreneurs.
What's next for RubiconMD?
With its recent major strategic investment, RubiconMD is poised for accelerated growth and further development of its core platforms. The substantial capital infusion is expected to fuel expansion into new markets, enhance its technological infrastructure, and potentially broaden its service offerings in eConsult and behavioral health. This funding will likely enable RubiconMD to solidify its market leadership and continue its trajectory of innovation in primary care technology, addressing critical needs in patient access and provider support.
See full RubiconMD company page
